Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia

The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of predominantly negative symptoms of schizop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Nemeth Gyoergy dr, Laszlovszky Istvan dr, Pitter Janos dr, Marc Debelle, Szatmari Balazs dr
Format: Patent
Sprache:eng ; hun
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Nemeth Gyoergy dr
Laszlovszky Istvan dr
Pitter Janos dr
Marc Debelle
Szatmari Balazs dr
description The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of predominantly negative symptoms of schizophrenia.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_HU231227B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>HU231227B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_HU231227B13</originalsourceid><addsrcrecordid>eNqFjTEKAjEQRbexEPUMplRwis0K9oriAbQSkTHOmkAyCUkQo3gGr-wi9lb_PXjw-9V7F5ETzOEp4TCHiZw1cDFKWx990MTFTiGYQBEfhqGGYo9AWRf7Ap5xl7qvKYxndL5YUEVZr-leLDrDJFofRY6E2fBVMF07uJFIxYXsXRK-FUlp8-jOIrHBYdVr0SYa_XZQjTfr3WoLFPyJUkBFTPm03cumlnKxrJv_xQdMF03y</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia</title><source>esp@cenet</source><creator>Nemeth Gyoergy dr ; Laszlovszky Istvan dr ; Pitter Janos dr ; Marc Debelle ; Szatmari Balazs dr</creator><creatorcontrib>Nemeth Gyoergy dr ; Laszlovszky Istvan dr ; Pitter Janos dr ; Marc Debelle ; Szatmari Balazs dr</creatorcontrib><description>The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of predominantly negative symptoms of schizophrenia.</description><language>eng ; hun</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220328&amp;DB=EPODOC&amp;CC=HU&amp;NR=231227B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220328&amp;DB=EPODOC&amp;CC=HU&amp;NR=231227B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Nemeth Gyoergy dr</creatorcontrib><creatorcontrib>Laszlovszky Istvan dr</creatorcontrib><creatorcontrib>Pitter Janos dr</creatorcontrib><creatorcontrib>Marc Debelle</creatorcontrib><creatorcontrib>Szatmari Balazs dr</creatorcontrib><title>Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia</title><description>The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of predominantly negative symptoms of schizophrenia.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFjTEKAjEQRbexEPUMplRwis0K9oriAbQSkTHOmkAyCUkQo3gGr-wi9lb_PXjw-9V7F5ETzOEp4TCHiZw1cDFKWx990MTFTiGYQBEfhqGGYo9AWRf7Ap5xl7qvKYxndL5YUEVZr-leLDrDJFofRY6E2fBVMF07uJFIxYXsXRK-FUlp8-jOIrHBYdVr0SYa_XZQjTfr3WoLFPyJUkBFTPm03cumlnKxrJv_xQdMF03y</recordid><startdate>20220328</startdate><enddate>20220328</enddate><creator>Nemeth Gyoergy dr</creator><creator>Laszlovszky Istvan dr</creator><creator>Pitter Janos dr</creator><creator>Marc Debelle</creator><creator>Szatmari Balazs dr</creator><scope>EVB</scope></search><sort><creationdate>20220328</creationdate><title>Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia</title><author>Nemeth Gyoergy dr ; Laszlovszky Istvan dr ; Pitter Janos dr ; Marc Debelle ; Szatmari Balazs dr</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_HU231227B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; hun</language><creationdate>2022</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Nemeth Gyoergy dr</creatorcontrib><creatorcontrib>Laszlovszky Istvan dr</creatorcontrib><creatorcontrib>Pitter Janos dr</creatorcontrib><creatorcontrib>Marc Debelle</creatorcontrib><creatorcontrib>Szatmari Balazs dr</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Nemeth Gyoergy dr</au><au>Laszlovszky Istvan dr</au><au>Pitter Janos dr</au><au>Marc Debelle</au><au>Szatmari Balazs dr</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia</title><date>2022-03-28</date><risdate>2022</risdate><abstract>The present invention relates to trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-N,N-dimethylcarbamoyl-cyclohexylamine (cariprazine) and pharmaceutically acceptable salts and hydrates and solvates and polymorphs thereof for use in the treatment of predominantly negative symptoms of schizophrenia.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; hun
recordid cdi_epo_espacenet_HU231227B1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Trans-4-{2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl}-n,n-dimethylcarbamoyl-cyclohexylamine for treating negative symptoms of schizophrenia
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A43%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Nemeth%20Gyoergy%20dr&rft.date=2022-03-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EHU231227B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true